RespireRx Pharmaceuticals Inc. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: RespireRx Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
RespireRx Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2023 was 14.8 %, a 37.8% decline year-over-year.
RespireRx Pharmaceuticals Inc. annual Return On Equity for 2022 was 18.5 %, a 46% decline from 2021.
RespireRx Pharmaceuticals Inc. annual Return On Equity for 2021 was 34.3 %, a 38.9% decline from 2020.
RespireRx Pharmaceuticals Inc. annual Return On Equity for 2020 was 56.1 %, a 81.3% increase from 2019.

Return On Equity, Annual (%)

Return On Equity, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
2022	18.5	-15.8	-46%	Jan 1, 2022	Dec 31, 2022
2021	34.3	-21.9	-38.9%	Jan 1, 2021	Dec 31, 2021
2020	56.1	+25.2	+81.3%	Jan 1, 2020	Dec 31, 2020
2019	31	-18.1	-36.9%	Jan 1, 2019	Dec 31, 2019
2018	49	-24.5	-33.3%	Jan 1, 2018	Dec 31, 2018
2017	73.5	-134	-64.5%	Jan 1, 2017	Dec 31, 2017
2016	207	-27.8	-11.8%	Jan 1, 2016	Dec 31, 2016
2015	235	+115	+95.5%	Jan 1, 2015	Dec 31, 2015
2014	120	+90.4	+304%	Jan 1, 2014	Dec 31, 2014
2013	29.8	-854	-96.6%	Jan 1, 2013	Dec 31, 2013
2012	884			Jan 1, 2012	Dec 31, 2012

Showing 1 to 11 of 11 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.